Sale by Kristen Williams of 1301 shares of Pacira Pharmaceuticals

PCRX Stock  USD 16.91  0.27  1.62%   
Slightly above 52% of Pacira BioSciences,'s investors are presently thinking to get in. The analysis of overall sentiment of trading Pacira BioSciences, stock suggests that some investors are interested at this time. Pacira BioSciences,'s investing sentiment can be driven by a variety of factors including economic data, Pacira BioSciences,'s earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Pacira Biosciences Inc officer. General open market or private sale of non-derivative or derivative security

Read at macroaxis.com
Pacira insider trading alert for sale of common stock by Kristen Williams, Chief Administrative Officer, on 7th of June 2023. This event was filed by Pacira Biosciences Inc with SEC on 2023-06-07. Statement of changes in beneficial ownership - SEC Form 4. Kristen Williams currently serves as chief administrative officer, general counsel, secretary of Pacira Pharmaceuticals

Cash Flow Correlation

Pacira BioSciences,'s cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Pacira BioSciences,'s relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Pacira BioSciences, Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Pacira BioSciences, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Pacira BioSciences, Historical Investor Sentiment

Investor biases related to Pacira BioSciences,'s public news can be used to forecast risks associated with an investment in Pacira. The trend in average sentiment can be used to explain how an investor holding Pacira can time the market purely based on public headlines and social activities around Pacira BioSciences,. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pacira BioSciences,'s market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pacira BioSciences, and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Pacira BioSciences, news discussions. The higher the estimate score, the more favorable the investor's outlook on Pacira BioSciences,.

Pacira BioSciences, Fundamental Analysis

We analyze Pacira BioSciences,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pacira BioSciences, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pacira BioSciences, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Earning

Price To Earning Comparative Analysis

Pacira BioSciences, is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Pacira BioSciences, Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pacira BioSciences, stock to make a market-neutral strategy. Peer analysis of Pacira BioSciences, could also be used in its relative valuation, which is a method of valuing Pacira BioSciences, by comparing valuation metrics with similar companies.

Peers

Pacira BioSciences, Related Equities

PBHPrestige Brand   0.71   
0%
8.0%
RDYDr Reddys   0.43   
0%
5.0%
COLLCollegium Pharmaceutical   0.68   
8.0%
0%
PAHCPhibro Animal   0.93   
11.0%
0%
ALKSAlkermes Plc   1.02   
12.0%
0%
ITCIIntracellular   1.09   
13.0%
0%
IXHLIncannex Healthcare   2.20   
27.0%
0%
ANIPANI Pharmaceuticals   3.64   
45.0%
0%
HCMHUTCHMED DRC   8.03   
100.0%
0%

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.